drugset / Trial / NCT02174094
Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate the effect on the frequency of tonic-clonic and clonic seizures of clobazam as adjunctive therapy compared to placebo after 16 weeks of treatment in paediatric patients aged ≥1 to ≤16 years with Dravet Syndrome.
Timeline
- Start
- 2015-03
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clobazam | Small molecule | 1 mg/kg | Oral |
| Subject | Clobazam | Small molecule | 1.5 mg/kg | Oral |
| Subject | Clobazam | Small molecule | 2 mg/kg | Oral |